0001181431-13-030075.txt : 20130523 0001181431-13-030075.hdr.sgml : 20130523 20130523143647 ACCESSION NUMBER: 0001181431-13-030075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130522 FILED AS OF DATE: 20130523 DATE AS OF CHANGE: 20130523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FERRARI LOUIS CENTRAL INDEX KEY: 0001513697 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15313 FILM NUMBER: 13867843 MAIL ADDRESS: STREET 1: 765 WARREN STREET CITY: WARRREN STREET STATE: NJ ZIP: 07090 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd380988.xml FERRARI FORM 4 X0306 4 2013-05-22 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001513697 FERRARI LOUIS SAVIENT PHARMACEUTICALS, INC. 400 CROSSING BLVD. BRIDGEWATER NJ 08807 1 1 0 0 President and CEO Common Stock 2013-05-22 4 S 0 1020 0.57 D 307439 D These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 21, 2011. Philip K. Yachmetz as attorney-in-fact for Louis Ferrari 2013-05-23